Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laheurte

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
International Journal of Cancer|August 10, 2019
CD4 T cells target colorectal cancer antigens upregulated by oxaliplatinJeanne Galaine, Célia Turco, Charline Vauchy, et al.
Transplant Immunology|September 25, 2017
Immune reconstitution with two different rabbit polyclonal anti-thymocytes globulinsJamal Bamoulid, Thomas Crepin, Emilie Gaiffe, et al.
Kidney International|April 17, 2016
Pretransplant thymic function predicts acute rejection in antithymocyte globulin-treated renal transplant recipientsJamal Bamoulid, Cécile Courivaud, Thomas Crepin, et al.
Cancer Immunology Research|November 19, 2014
Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activityJeremy Bastid, Anne Regairaz, Nathalie Bonnefoy, et al.
Oncoimmunology|July 29, 2016
Immunoprevalence and magnitude of HLA-DP4 versus HLA-DR-restricted spontaneous CD4(+) Th1 responses against telomerase in cancer patientsCaroline Laheurte, Jeanne Galaine, Laurent Beziaud, et al.
Frontiers in Immunology|June 24, 2021
New Insights on End-Stage Renal Disease and Healthy Individual Gut Bacterial Translocation: Different Carbon Composition of Lipopolysaccharides and Different Impact on Monocyte Inflammatory ResponseHanane Adda-Rezig, Clémence Carron, Jean-Paul Pais de Barros, et al.
Cell Reports. Medicine|June 21, 2025
UCPVax, a CD4 helper peptide vaccine, induces polyfunctional Th1 cells, antibody response, and epitope spreading to improve antitumor immunityCaroline Laheurte, Laura Boullerot, Babacar Ndao, et al.
British Journal of Cancer|July 31, 2019
Distinct prognostic value of circulating anti-telomerase CD4<sup>+</sup> Th1 immunity and exhausted PD-1<sup>+</sup>/TIM-3<sup>+</sup> T cells in lung cancerCaroline Laheurte, Magalie Dosset, Dewi Vernerey, et al.
Oncoimmunology|February 5, 2019
Circulating NKp46<sup>+</sup> Natural Killer cells have a potential regulatory property and predict distinct survival in Non-Small Cell Lung CancerEmilie Picard, Yann Godet, Caroline Laheurte, et al.
Oncoimmunology|February 27, 2026
Multidimensional immune profiling uncovers biphasic peripheral T-cell dynamics after chemoradiation in patients with locally advanced head and neck cancerBenoît Lecoester, Yaoyao Xie, Xushan Sun, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
International Journal of Cancer|August 10, 2019
CD4 T cells target colorectal cancer antigens upregulated by oxaliplatinJeanne Galaine, Célia Turco, Charline Vauchy, et al.
Transplant Immunology|September 25, 2017
Immune reconstitution with two different rabbit polyclonal anti-thymocytes globulinsJamal Bamoulid, Thomas Crepin, Emilie Gaiffe, et al.
Kidney International|April 17, 2016
Pretransplant thymic function predicts acute rejection in antithymocyte globulin-treated renal transplant recipientsJamal Bamoulid, Cécile Courivaud, Thomas Crepin, et al.
Cancer Immunology Research|November 19, 2014
Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activityJeremy Bastid, Anne Regairaz, Nathalie Bonnefoy, et al.
Oncoimmunology|July 29, 2016
Immunoprevalence and magnitude of HLA-DP4 versus HLA-DR-restricted spontaneous CD4(+) Th1 responses against telomerase in cancer patientsCaroline Laheurte, Jeanne Galaine, Laurent Beziaud, et al.
Frontiers in Immunology|June 24, 2021
New Insights on End-Stage Renal Disease and Healthy Individual Gut Bacterial Translocation: Different Carbon Composition of Lipopolysaccharides and Different Impact on Monocyte Inflammatory ResponseHanane Adda-Rezig, Clémence Carron, Jean-Paul Pais de Barros, et al.
Cell Reports. Medicine|June 21, 2025
UCPVax, a CD4 helper peptide vaccine, induces polyfunctional Th1 cells, antibody response, and epitope spreading to improve antitumor immunityCaroline Laheurte, Laura Boullerot, Babacar Ndao, et al.
British Journal of Cancer|July 31, 2019
Distinct prognostic value of circulating anti-telomerase CD4<sup>+</sup> Th1 immunity and exhausted PD-1<sup>+</sup>/TIM-3<sup>+</sup> T cells in lung cancerCaroline Laheurte, Magalie Dosset, Dewi Vernerey, et al.
Oncoimmunology|February 5, 2019
Circulating NKp46<sup>+</sup> Natural Killer cells have a potential regulatory property and predict distinct survival in Non-Small Cell Lung CancerEmilie Picard, Yann Godet, Caroline Laheurte, et al.
Oncoimmunology|February 27, 2026
Multidimensional immune profiling uncovers biphasic peripheral T-cell dynamics after chemoradiation in patients with locally advanced head and neck cancerBenoît Lecoester, Yaoyao Xie, Xushan Sun, et al.
Pageof 7